Advanced company searchLink opens in new window

GENEVANT SCIENCES HOLDINGS LIMITED

Company number 11134297

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
15 Jan 2025 CS01 Confirmation statement made on 4 January 2025 with no updates
16 Dec 2024 SH19 Statement of capital on 16 December 2024
  • USD 20,563
16 Dec 2024 SH20 Statement by Directors
16 Dec 2024 CAP-SS Solvency Statement dated 08/12/24
16 Dec 2024 RESOLUTIONS Resolutions
  • RES13 ‐ Share premium account reduced 08/12/2024
11 Jan 2024 CS01 Confirmation statement made on 4 January 2024 with updates
23 Dec 2023 AA Full accounts made up to 31 March 2023
06 Oct 2023 TM01 Termination of appointment of Mark Craig as a director on 6 October 2023
06 Oct 2023 AP01 Appointment of Ms Emma Carys Price as a director on 6 October 2023
09 Mar 2023 SH01 Statement of capital following an allotment of shares on 6 March 2023
  • USD 20,563
09 Jan 2023 CS01 Confirmation statement made on 4 January 2023 with updates
19 Dec 2022 AA Full accounts made up to 31 March 2022
12 Oct 2022 AD01 Registered office address changed from Suite 1, 3rd Floor 11 - 12 st. James's Square London SW1Y 4LB United Kingdom to 7th Floor 50 Broadway London SW1H 0DB on 12 October 2022
22 Apr 2022 PSC02 Notification of Roivant Sciences Ltd. as a person with significant control on 1 October 2021
22 Apr 2022 PSC09 Withdrawal of a person with significant control statement on 22 April 2022
08 Apr 2022 SH01 Statement of capital following an allotment of shares on 30 March 2022
  • USD 20,562
04 Jan 2022 CS01 Confirmation statement made on 4 January 2022 with no updates
16 Dec 2021 AA Full accounts made up to 31 March 2021
04 Jan 2021 CS01 Confirmation statement made on 4 January 2021 with no updates
16 Dec 2020 AA Full accounts made up to 31 March 2020
07 Jan 2020 CS01 Confirmation statement made on 4 January 2020 with updates
01 Nov 2019 TM01 Termination of appointment of Evia Mary Soussi as a director on 1 November 2019
01 Nov 2019 AP01 Appointment of Mr Mark Craig as a director on 1 November 2019
06 Aug 2019 AA Full accounts made up to 31 March 2019
26 Apr 2019 SH01 Statement of capital following an allotment of shares on 29 March 2019
  • USD 20,561